HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$5.84
Day range
$6.10 - $7.10
Year range
$1.37 - $8.65
Market cap
22.64M USD
Avg Volume
1.63M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.79M | -23.17% |
Net income | -1.72M | 22.03% |
Net profit margin | — | — |
Earnings per share | -0.50 | 37.50% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.12M | -30.15% |
Total assets | 7.18M | -30.55% |
Total liabilities | 1.09M | -56.45% |
Total equity | 6.09M | — |
Shares outstanding | 3.52M | — |
Price to book | 3.38 | — |
Return on assets | -55.58% | — |
Return on capital | -65.92% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.72M | 22.03% |
Cash from operations | -1.68M | 20.21% |
Cash from investing | -2.42K | -100.08% |
Cash from financing | -9.92K | -101.55% |
Net change in cash | -1.69M | -213.33% |
Free cash flow | -1.07M | 21.85% |
About
Founded
2014
Headquarters
Website
Employees
10
